{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:20:26Z","timestamp":1740028826555,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1124\/jpet.103.063610","type":"journal-article","created":{"date-parts":[[2004,4,22]],"date-time":"2004-04-22T00:29:43Z","timestamp":1082593783000},"page":"498-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacological Characterization of N-tert-Butyl-N\u2032-[2-(4\u2032-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time"],"prefix":"10.1016","volume":"309","author":[{"given":"Jean-Michel","family":"Dogn\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Tchana-Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Rolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Ghuysen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Segers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Lambermont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Masereel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Pirotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.063610_bib1","doi-asserted-by":"crossref","unstructured":"Awtry EH and Loscalzo J (2000) Aspirin. Circulation 101: 1206-1218.","DOI":"10.1161\/01.CIR.101.10.1206"},{"key":"10.1124\/jpet.103.063610_bib2","doi-asserted-by":"crossref","unstructured":"Bhagwat SS, Hamann PR, Still WC, Bunting S, and Fitzpatrick FA (1985) Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature (Lond) 315: 511-513.","DOI":"10.1038\/315511a0"},{"key":"10.1124\/jpet.103.063610_bib3","doi-asserted-by":"crossref","unstructured":"Born GV and Cross MF (1963) The aggregation of blood platelets. J Physiol 168: 178-195.","DOI":"10.1113\/jphysiol.1963.sp007185"},{"key":"10.1124\/jpet.103.063610_bib4","doi-asserted-by":"crossref","unstructured":"Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, and Fitzgerald GA (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science (Wash DC) 296: 539-541.","DOI":"10.1126\/science.1068711"},{"key":"10.1124\/jpet.103.063610_bib5","doi-asserted-by":"crossref","unstructured":"Cocks TM, King SJ, and Angus JA (1990) Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro. Br J Pharmacol 100: 375-378.","DOI":"10.1111\/j.1476-5381.1990.tb15812.x"},{"key":"10.1124\/jpet.103.063610_bib6","doi-asserted-by":"crossref","unstructured":"Collins R, Baigent C, Sandercock P, and Peto R (1994) Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists\u2019 Collaboration. Br Med J 309: 1215-1217.","DOI":"10.1136\/bmj.309.6963.1215"},{"key":"10.1124\/jpet.103.063610_bib7","doi-asserted-by":"crossref","unstructured":"de Leval X, Hanson J, David JL, Masereel, Pirotte B, and Dogn\u00e9 JM (2004) New developments on thromboxane and prostacyclin modulators. Part II: prostacyclin modulators. Curr Med Chem, in press.","DOI":"10.2174\/0929867043365279"},{"key":"10.1124\/jpet.103.063610_bib8","doi-asserted-by":"crossref","unstructured":"Dogn\u00e9 JM, de Leval X, Delarge J, David JL, and Masereel B (2000) New trends in thromboxane and prostacyclin modulators. Curr Med Chem 7: 609-628.","DOI":"10.2174\/0929867003374868"},{"key":"10.1124\/jpet.103.063610_bib9","doi-asserted-by":"crossref","unstructured":"Dogn\u00e9 JM, de Leval X, Hanson J, Frederich M, Lambermont B, Ghuysen A, Casini A, Masereel B, Ruan KH, Pirotte B, et al. (2004) New developments on thromboxane and prostacyclin modulators. Part I: thromboxane modulators. Curr Med Chem, in press.","DOI":"10.2174\/0929867043365260"},{"key":"10.1124\/jpet.103.063610_bib10","doi-asserted-by":"crossref","unstructured":"Dogn\u00e9 JM, de Leval X, Kolh P, Sanna V, Rolin S, Michaux C, Mauer M, David JL, Masereel B, and Pirotte B (2003) Pharmacological evaluation of the novel thromboxane modulator BM-567 (I\/II). Effects of BM-567 on platelet function. Prostaglandins Leukotrienes Essent Fatty Acids 68: 49-54.","DOI":"10.1016\/S0952-3278(02)00236-3"},{"key":"10.1124\/jpet.103.063610_bib11","doi-asserted-by":"crossref","unstructured":"Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, and Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105: 1650-1655.","DOI":"10.1161\/01.CIR.0000013777.21160.07"},{"key":"10.1124\/jpet.103.063610_bib12","unstructured":"Fiddler GI and Lumley P (1990) Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review. Circulation (Suppl 1) 81: I69-78."},{"key":"10.1124\/jpet.103.063610_bib13","doi-asserted-by":"crossref","unstructured":"Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ Jr, Wiekowski MT, et al. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Investig 107: 1591-1598.","DOI":"10.1172\/JCI12242"},{"key":"10.1124\/jpet.103.063610_bib14","doi-asserted-by":"crossref","unstructured":"Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, and Leurgans S (2003) Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 289: 2947-2957.","DOI":"10.1001\/jama.289.22.2947"},{"key":"10.1124\/jpet.103.063610_bib15","doi-asserted-by":"crossref","unstructured":"Hamberg M, Svensson J, and Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994-2998.","DOI":"10.1073\/pnas.72.8.2994"},{"key":"10.1124\/jpet.103.063610_bib16","doi-asserted-by":"crossref","unstructured":"Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, and Weber PC (1987) Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 10: 998-1006.","DOI":"10.1016\/S0735-1097(87)80336-4"},{"key":"10.1124\/jpet.103.063610_bib17","doi-asserted-by":"crossref","unstructured":"Kim YS, Pyo MK, Park KM, Park PH, Hahn BS, Wu SJ, and Yun-Choi HS (1998) Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). Thromb Res 91: 33-38.","DOI":"10.1016\/S0049-3848(98)00075-9"},{"key":"10.1124\/jpet.103.063610_bib18","doi-asserted-by":"crossref","unstructured":"Koba S, Pakala R, Watanabe T, Katagiri T, and Benedict CR (2000) Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation. Prostaglandins Leukotrienes Essent Fatty Acids 63: 329-335.","DOI":"10.1054\/plef.2000.0223"},{"key":"10.1124\/jpet.103.063610_bib19","doi-asserted-by":"crossref","unstructured":"Kurz KD, Main BW, and Sandusky GE (1990) Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 60: 269-280.","DOI":"10.1016\/0049-3848(90)90106-M"},{"key":"10.1124\/jpet.103.063610_bib20","doi-asserted-by":"crossref","unstructured":"Lebrun P, Arkhammar P, Antoine MH, Nguyen QA, Hansen JB, and Pirotte B (2000) A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release. Diabetologia 43: 723-732.","DOI":"10.1007\/s001250051370"},{"key":"10.1124\/jpet.103.063610_bib21","doi-asserted-by":"crossref","unstructured":"Li P, Ferrario CM, and Brosnihan KB (1998) Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats. J Cardiovasc Pharmacol 32: 198-205.","DOI":"10.1097\/00005344-199808000-00005"},{"key":"10.1124\/jpet.103.063610_bib22","unstructured":"Lo\u00ef C, Chardigny JM, Berdeaux O, Vatele JM, Poullain D, Noel JP, and Sebedio JL (1998) Effects of three trans isomers of eicosapentaenoic acid on rat platelet aggregation and arachidonic acid metabolism. Thromb Haemostasis 80: 656-661."},{"key":"10.1124\/jpet.103.063610_bib23","doi-asserted-by":"crossref","unstructured":"Ma H, Hara A, Xiao CY, Okada Y, Takahata O, Nakaya K, Sugimoto Y, Ichikawa A, Narumiya S, and Ushikubi F (2001) Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3). Circulation 104: 1176-1180.","DOI":"10.1161\/hc3601.094003"},{"key":"10.1124\/jpet.103.063610_bib24","doi-asserted-by":"crossref","unstructured":"Mangano DT (2002) Multicenter study of perioperative ischemia research group aspirin and mortality from coronary bypass surgery. N Engl J Med 347: 1309-1317.","DOI":"10.1056\/NEJMoa020798"},{"key":"10.1124\/jpet.103.063610_bib25","doi-asserted-by":"crossref","unstructured":"Masereel B, Schynts M, Krzesinski JM, Pirotte B, Rorive G, and Delarge J (1993) A sulphonylthiourea (BM 20) related to torasemide: a new loop diuretic with relative potassium-sparing properties. J Pharm Pharmacol 45: 720-724.","DOI":"10.1111\/j.2042-7158.1993.tb07096.x"},{"key":"10.1124\/jpet.103.063610_bib26","doi-asserted-by":"crossref","unstructured":"Pakala R and Benedict CR (1998) Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists. J Lab Clin Med 131: 527-537.","DOI":"10.1016\/S0022-2143(98)90061-0"},{"key":"10.1124\/jpet.103.063610_bib27","doi-asserted-by":"crossref","unstructured":"Pinsky PF, Hurwitz ES, Schonberger LB, and Gunn WJ (1988) Reye\u2019s syndrome and aspirin. Evidence for a dose-response effect. JAMA 260: 657-661.","DOI":"10.1001\/jama.260.5.657"},{"key":"10.1124\/jpet.103.063610_bib28","doi-asserted-by":"crossref","unstructured":"Rolin S, Dogne JM, Michaux C, Delarge J, and Masereel B (2001) Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles. Prostaglandins Leukotrienes Essent Fatty Acids 65: 67-72.","DOI":"10.1054\/plef.2001.0290"},{"key":"10.1124\/jpet.103.063610_bib29","doi-asserted-by":"crossref","unstructured":"Saldeen TG, Saldeen P, Nichols WW, Lawson DL, Nicolini FA, and Mehta JL (1993) Increased production of thromboxane A2 by coronary arteries after thrombolysis. Am Heart J 125: 277-284.","DOI":"10.1016\/0002-8703(93)90001-P"},{"key":"10.1124\/jpet.103.063610_bib30","doi-asserted-by":"crossref","unstructured":"Stanke F, Cracowski JL, Chavanon O, Magne JL, Blin D, Bessard G, and Devillier P (1998) Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein. Eur J Pharmacol 341: 65-71.","DOI":"10.1016\/S0014-2999(97)01458-1"},{"key":"10.1124\/jpet.103.063610_bib31","doi-asserted-by":"crossref","unstructured":"Svensson J, Hamberg M, and Samuelsson B (1976) On the formation and effects of thromboxane A2 in human platelets. Acta Physiol Scand 98: 285-294.","DOI":"10.1111\/j.1748-1716.1976.tb10313.x"},{"key":"10.1124\/jpet.103.063610_bib32","doi-asserted-by":"crossref","unstructured":"Tanaka T, Ito S, Higashino R, Fukuta Y, Fukuda Y, Takei M, Kurimoto T, and Tamaki H (1998) A new thromboxane receptor antagonist, Z-335, ameliorates experimental thrombosis without prolonging the rat tail bleeding time. Thromb Res 91: 229-235.","DOI":"10.1016\/S0049-3848(98)00103-0"},{"key":"10.1124\/jpet.103.063610_bib33","doi-asserted-by":"crossref","unstructured":"Tanaka T, Sato R, and Kurimoto T (2000) Z-335, a new thromboxane A(2) receptor antagonist, prevents arterial thrombosis induced by ferric chloride in rats. Eur J Pharmacol 401: 413-418.","DOI":"10.1016\/S0014-2999(00)00434-9"},{"key":"10.1124\/jpet.103.063610_bib34","doi-asserted-by":"crossref","unstructured":"Uchida T, Kido H, Yamanaga K, Okita M, and Watanabe M (1992) A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery. Prostaglandins Leukotrienes Essent Fatty Acids 45: 121-124.","DOI":"10.1016\/0952-3278(92)90227-A"},{"key":"10.1124\/jpet.103.063610_bib35","doi-asserted-by":"crossref","unstructured":"Wittner M, Di Stefano A, Schlatter E, Delarge J, and Greger R (1986) Torasemide inhibits NaCl reabsorption in the thick ascending limb of the loop of Henle. Pflugers Arch 407: 611-614.","DOI":"10.1007\/BF00582640"},{"key":"10.1124\/jpet.103.063610_bib36","doi-asserted-by":"crossref","unstructured":"Wittner M, Di Stefano A, Wangemann P, Delarge J, Liegeois JF, and Greger R (1987) Analogues of torasemide\u2013structure function relationships\u2013experiments in the thick ascending limb of the loop of Henle of rabbit nephron. Pflugers Arch 408: 54-62.","DOI":"10.1007\/BF00581840"},{"key":"10.1124\/jpet.103.063610_bib37","doi-asserted-by":"crossref","unstructured":"Yokoyama K, Kudo I, Nakamura H, and Inoue K (1994) A possible role for extracellular bicarbonate in U-46619-induced rat platelet aggregation. Thromb Res 74: 369-376.","DOI":"10.1016\/0049-3848(94)90152-X"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524313060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524313060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.063610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:51:52Z","timestamp":1739998312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524313060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022356524313060"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.063610","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of N-tert-Butyl-N\u2032-[2-(4\u2032-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.063610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}